ISX-3 is a small molecule that promotes bone formation and inhibits fat cell differentiation by modulating PPARgamma expression. It is a valuable research tool for studying bone loss mechanisms in models of osteopenia and osteoporosis, applicable in both in vitro and in vivo experimental settings.